Nitric oxide inhalation in pulmonary hypertension and severe respiratory failure

Current Opinion in Cardiology

Volumn 14, Issue 5, 1999, Pages 432-436

  Max, Martin ^a,b   Rossaint, Rolf ^a,b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ARTERIAL OXYGEN SATURATION; CONGENITAL HEART MALFORMATION; GAS EXCHANGE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MORTALITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; REVIEW; SURVIVAL; VASODILATATION;

ADMINISTRATION, INHALATION; HUMANS; HYPERTENSION, PULMONARY; NITRIC OXIDE; RESPIRATORY INSUFFICIENCY; SURVIVAL RATE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0032826175     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199909000-00012     Document Type: Review

References (40)

1. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987, 84:9265-9269.
2. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
3. Troncy E, Francoeur M, Blaise G: Inhaled nitric oxide: clinical applications, indications, and toxicology. Can J Anaesth 1997, 44:973-988.
4. Giaid A, Salch D: Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995, 333:214-221.
5. Weir EK, Schremmer B: Vasodilators in the treatment of primary pulmonary hypertension. Eur Respir J 1998, 12:263-264.
6. Sitbon O, Humbert M, Jagot JL, Taravella O, Fartoukh M, Parent F, et al.: Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J 1998, 12:265-270.
7. Martin EB, Tolarova S, Weir EK: Aerosol delivery of detano, a nitric oxide adduct, causes selective and sustained perinatal pulmonary vasodilation. Pediatr Res 1996, 39:339A.
8. Zapol WM, Jones R: Vascular components of ARDS. Am Rev Respir Dis 1987, 136:471-474.
9. Iotti GA, Olivei MC, Palo A, Galbusera C, Veronesi R, Braschi A: Acute effects of inhaled nitric oxide in adult respiratory distress syndrome. Eur Respir J 1998, 12:1164-1171.
10. Rossaint R, Slama K, Steudel W, Gerlach H, Pappert D, Veit S, Falke K: Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med 1995, 21:197-203.
11. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, et al.: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998, 26:15-23. This large, multicenter, randomized, double-blind, placebo-controlled study failed to show an effect of NO inhalation on mortality in ARDS.
12. Barbera JA, Roger N, Roca J, Rovira I, Higenbottam T, Rodriguez Roisin R: Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive lung disease. Lancet 1996, 347:436-440.
13. Roger N, Barbera JA, Roca J, Rovira I, Gomez FP, Rodriguez RR: Nitric oxide inhalation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997, 156:800-806.
14. Adnot S, Kouyoumdjian C, Defouilloy C, Andrivet P, Sediame S, Herigault R, Fratacci MD: Hemodynamic and gas exchange responses to infusion of acetytcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 1993, 148:310-316.
15. Roberts JD, Fineman JR, Morin FC, Shaul PW, Rimar S, Schreiber MD, et al.: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997, 336:605-610.
16. Hoffman GM, Ross GA, Day SE, Rice TB, Nelin LD: Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 1997, 25:352-359.
17. The Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997, 336:597-604.
18. Roberts JD, Fineman JR, Morin FC, Shaul PW, Rimar S, Schreiber MD, et al.: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997, 336:605-610.
19. Cholley BP, Hilbert U, Guinard N, Mateo J, Payen D: Improvement of extreme hypoxemia during end-stage congenital heart disease using nasal nitric oxide. Anesthesiology 1998, 89:1586-1587.
20. Russell IA, Zwass MS, Fineman JR, Balea M, Rouine RK, Brook M, et al: The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998, 87:46-51.
21. Schulze-Neick I, Bultmann M, Werner H, Gamillscheg A, Vogel M, Berger F, et al.: Right ventricular function in patients treated with inhaled nitric oxide after cardiac surgery for congenital heart disease in newborns and children. Am J Cardiol 1997, 80:360-363.
22. Rossaint R, Falke KJ, Lopez FA, Slama K, Pison U, Zapol WM: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993, 328:399-405.
23. Troncy E, Collet JP, Shapiro S, Guimond JG, Blair L, Ducruet T, et al.: Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med 1998, 157:1483-1488. This study did not find an NO-dependent change in survival of patients with ARDS. This confirms the results of earlier investigations.
24. Michael JR, Barton RG, Saffle JR, Mone M, Markewitz BA, Hillier K, et al.: Inhaled nitric oxide versus conventional therapy. Effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998, 157:1372-1380. This randomized, controlled clinical trial systematically compared the effects of inhaled NO and conventional therapy on arterial oxygenation in ARDS.
25. Day RW, Allen EM, Witte MK: A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure. Chest 1997, 112:1324-1331.
26. Reyes A, Roca J, Rodriguez-Roisin R, Torres A, Ussetti P, Wagner P: Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Am Rev Respir Dis 1988, 137:1062-1067.
27. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al.: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
28. Gallart L, Lu Q, Puybasset L, Umamaheswara R, Coriat P, Rouby JJ, the NO Almitrine Study Group: Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome. Am J Respir Crit Care Med 1998, 158:1770-1777. The combination of inhaled NO and almitrine can have a greater effect on oxygenation in ARDS than either drug alone.
29. B'chir A, Mebazaa A, Losser MR, Romieu M, Payen D: Intravenous almitrine bismesylate reversibly induces lactic acidosis and hepatic dysfunction in patients with acute lung injury. Anesthesiology 1998, 89:823-830.
30. Lamm WJ, Graham MM, Albert RK: Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 1994, 150:184-193.
31. Germann P, Pöschl G, Leitner C, Urak G, Ullrich R, Faryniak B, et al.: Additive effect of nitric oxide inhalation on the oxygenation benefit of the prone position in the adult respiratory distress syndrome. Anesthesiology 1998, 89:1401-1406.
32. Fridrich P, Krafft P, Hochleuthner H, Mauritz W: The effects of long-term prone positioning in patients with trauma-induced adult respiratory distress syndrome. Anesth Analg 1996, 83:1206-1211.
33. Gillart T, Bazin JE, Cosserant B, Guelon D, Aigouy L, Manssor O, Schoeffler P; Combined nitric oxide inhalation, prone positioning and almitrine infusion improve oxygenation in severe ARDS. Can J Anaesth 1998, 45:402-409.
34. Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C, European Study Group of Inhaled Nitric Oxide: Inhalation of nitric oxide in acute lung injury: preliminary results of a European multicenter study [abstract]. Intensive Care Med 1997, 23:S2.
35. Groupe d'Etude sur le NO inhalé au cours de l'ARDS.: Inhaled NO in ARDS: presentation of a double-blinded, randomized multicentric study [abstract]. Am J Respir Crit Care Med 1996, 153:A590.
36. Beloucif S, Payen D: A European survey of the use of inhaled nitric oxide in the ICU. Intensive Care Med 1998, 24:864-877.
37. Payen D: Is nitric oxide inhalation a "cosmetic" therapy in acute respiratory distress syndrome? Am J Respir Crit Care Med 1998, 157:1361-1362. This highly informative editorial discusses the future of NO inhalation.
38. Chollet-Martin S, Gatecel C, Kermarrec N, Gougerot-Pocidalo MA, Payen D: Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 1996, 153:985-990.
39. Lavoie A, Hall JB, Olson DM, Wylan ME: Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med 1996, 153:1985-1987.
40. Cueto E, Lopez HJ, Sanchez A, Carrillo A: Life-threatening effects of discontinuing inhaled nitric oxide in children. Acta Paediatr 1997, 86:1337-1339.